HSBC Holdings
AKBA icon

HSBC Holdings’s Akebia Therapeutics AKBA Stock Holding History

HSBC Holdings’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.9K Sell
23,677
-124,415
-84% -$148K ﹤0.01% 2889
2026
Q1 		$206K Buy
+148,092
New +$204K ﹤0.01% 2600
2025
Q3 		– Sell
-28,309
Closed -$104K – 2702
2025
Q2 		$104K Sell
28,309
-42,525
-60% -$117K ﹤0.01% 2839
2025
Q1 		$135K Buy
70,834
+829
+1% +$1.69K ﹤0.01% 2731
2024
Q4 		$131K Buy
70,005
+15,032
+27% +$26.1K ﹤0.01% 2833
2024
Q3 		$72.6K Buy
+54,973
New +$73.4K ﹤0.01% 2845
2022
Q2 		– Sell
-69,107
Closed -$49K – 3218
2022
Q1 		$49K Sell
69,107
-25,028
-27% -$53.5K ﹤0.01% 3201
2021
Q4 		$215K Buy
94,135
+55,073
+141% +$150K ﹤0.01% 2994
2021
Q3 		$112K Hold
39,062
– – ﹤0.01% 2876
2021
Q2 		$148K Hold
39,062
– – ﹤0.01% 2803
2021
Q1 		$132K Sell
39,062
-13,062
-25% -$47K ﹤0.01% 2607
2020
Q4 		$146K Sell
52,124
-11,338
-18% -$33.1K ﹤0.01% 2894
2020
Q3 		$158K Buy
63,462
+35,532
+127% +$312K ﹤0.01% 2536
2020
Q2 		$379K Sell
27,930
-2,189
-7% -$22.6K ﹤0.01% 2004
2020
Q1 		$234K Buy
30,119
+4,264
+16% +$33.2K ﹤0.01% 2197
2019
Q4 		$168K Sell
25,855
-144,656
-85% -$688K ﹤0.01% 2850
2019
Q3 		$668K Buy
+170,511
New +$731K ﹤0.01% 2161

Other funds holding AKBA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HSBC Holdings's AKBA Position: Q2 2026 in Review

HSBC Holdings reduced its Akebia Therapeutics (AKBA) stake by 84% in Q2 2026, selling an estimated $148K and leaving 23,677 shares worth $26.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2889.

HSBC Holdings first reported a position in AKBA in Q3 2019 and has held it in 17 quarters since. The position peaked at $668K in Q3 2019. 171 funds tracked by Wall St. Rank hold AKBA as of Q2 2026.

  • HSBC Holdings held 23,677 shares of Akebia Therapeutics worth $26.9K as of Q2 2026.
  • HSBC Holdings sold 124,415 Akebia Therapeutics shares in Q2 2026, an estimated $148K.
  • Akebia Therapeutics made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2889 holding.
  • HSBC Holdings first reported a position in Akebia Therapeutics in Q3 2019 and has held it in 17 quarters since.
  • HSBC Holdings's Akebia Therapeutics position peaked at $668K in Q3 2019.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.